Martiniakova M, Sarocka A, Penzes N, Biro R, Kovacova V, Mondockova V
Nutrients. 2025; 17(2).
PMID: 39861406
PMC: 11767469.
DOI: 10.3390/nu17020275.
Casertano M, Vito A, Aiello A, Imperatore C, Menna M
Pharmaceutics. 2023; 15(9).
PMID: 37765290
PMC: 10538088.
DOI: 10.3390/pharmaceutics15092321.
Naz R, Saqib F, Awadallah S, Wahid M, Latif M, Iqbal I
Molecules. 2023; 28(10).
PMID: 37241737
PMC: 10222362.
DOI: 10.3390/molecules28103996.
Kotha S, Kumar Gupta N, Ansari S
IUCrdata. 2022; 6(Pt 4):x210322.
PMID: 36339107
PMC: 9462329.
DOI: 10.1107/S2414314621003229.
Gudzuhn M, Alio I, Moll R, de Vries J, Boehlich J, Assmann M
Microbiol Spectr. 2022; 10(3):e0258221.
PMID: 35471093
PMC: 9241881.
DOI: 10.1128/spectrum.02582-21.
Inhibition of Aldose Reductase by Ginsenoside Derivatives via a Specific Structure Activity Relationship with Kinetics Mechanism and Molecular Docking Study.
Ali M, Zaib S, Jannat S, Khan I, Rahman M, Park S
Molecules. 2022; 27(7).
PMID: 35408532
PMC: 9000482.
DOI: 10.3390/molecules27072134.
Dual Targeting of PTP1B and Aldose Reductase with Marine Drug Phosphoeleganin: A Promising Strategy for Treatment of Type 2 Diabetes.
Genovese M, Imperatore C, Casertano M, Aiello A, Balestri F, Piazza L
Mar Drugs. 2021; 19(10).
PMID: 34677434
PMC: 8540617.
DOI: 10.3390/md19100535.
Glycation in Huntington's Disease: A Possible Modifier and Target for Intervention.
Bras I, Konig A, Outeiro T
J Huntingtons Dis. 2019; 8(3):245-256.
PMID: 31322580
PMC: 6839463.
DOI: 10.3233/JHD-190366.
Natural Products Diversity of Marine Ascidians (Tunicates; Ascidiacea) and Successful Drugs in Clinical Development.
Palanisamy S, Rajendran N, Marino A
Nat Prod Bioprospect. 2017; 7(1):1-111.
PMID: 28097641
PMC: 5315671.
DOI: 10.1007/s13659-016-0115-5.
Advancements in tetronic acid chemistry. Part 2: Use as a simple precursor to privileged heterocyclic motifs.
Abdou M, El-Saeed R, Elattar K, Seferoglu Z, Boukouvalas J
Mol Divers. 2016; 20(4):989-999.
PMID: 27350109
DOI: 10.1007/s11030-016-9683-x.
Esculetin, a Coumarin Derivative, Inhibits Aldose Reductase Activity in vitro and Cataractogenesis in Galactose-Fed Rats.
Kim C, Kim J, Lee Y, Sohn E, Kim J
Biomol Ther (Seoul). 2016; 24(2):178-83.
PMID: 26902086
PMC: 4774499.
DOI: 10.4062/biomolther.2015.101.
Gold-catalyzed formation of pyrrolo- and indolo-oxazin-1-one derivatives: The key structure of some marine natural products.
Taskaya S, Menges N, Balci M
Beilstein J Org Chem. 2015; 11:897-905.
PMID: 26124892
PMC: 4464457.
DOI: 10.3762/bjoc.11.101.
Inhibitory effects of Colocasia esculenta (L.) Schott constituents on aldose reductase.
Li H, Hwang S, Kang B, Hong J, Lim S
Molecules. 2014; 19(9):13212-24.
PMID: 25255750
PMC: 6271131.
DOI: 10.3390/molecules190913212.
Antimicrobial rubrolides from a South African species of Synoicum tunicate.
Sikorska J, Parker-Nance S, Davies-Coleman M, Vining O, Sikora A, McPhail K
J Nat Prod. 2012; 75(10):1824-7.
PMID: 23030848
PMC: 3549467.
DOI: 10.1021/np300580z.
2-(N-Phenyl-methane-sulfonamido)-ethyl 1H-pyrrole-2-carboxyl-ate.
Khan S, Yu P, Nelofar A, Ahmed Z, Chantrapromma S
Acta Crystallogr Sect E Struct Rep Online. 2011; 67(Pt 5):o1125-6.
PMID: 21754438
PMC: 3089296.
DOI: 10.1107/S160053681101261X.
Marine pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous....
Mayer A, Rodriguez A, Berlinck R, Hamann M
Biochim Biophys Acta. 2009; 1790(5):283-308.
PMID: 19303911
PMC: 2735450.
DOI: 10.1016/j.bbagen.2009.03.011.
Lamellarins and related pyrrole-derived alkaloids from marine organisms.
Fan H, Peng J, Hamann M, Hu J
Chem Rev. 2007; 108(1):264-87.
PMID: 18095718
PMC: 4928200.
DOI: 10.1021/cr078199m.
